{"id":43817,"date":"2022-01-24T01:18:19","date_gmt":"2022-01-24T01:18:19","guid":{"rendered":"https:\/\/jazairhope.org\/?p=43817"},"modified":"2022-01-24T01:18:19","modified_gmt":"2022-01-24T01:18:19","slug":"saidal-acquires-its-first-bio-equivalence-center","status":"publish","type":"post","link":"https:\/\/jazairhope.org\/en\/saidal-acquires-its-first-bio-equivalence-center\/","title":{"rendered":"SAIDAL acquires its first bio-equivalence center"},"content":{"rendered":"
The pharmaceutical group Saidal has set up its first bioequivalence center which will start operating \u201cin less than two weeks\u201d, declared Fatoum Akacem, CEO of the pharmaceutical group, on Radio Chaine III.<\/strong><\/p>\n \u201cThis center is used to demonstrate that a generic drug is a true copy of the parent molecule (\u2026) which will greatly facilitate the export of Algerian pharmaceutical products since it is an important regulatory requirement\u201d, said delighted, Fatum Akacem.<\/p>\n \u201cThe center will be called upon to carry out bio-equivalence for multinationals operating in Algeria\u201d, specifies a manager.<\/p>\n According to her, the center is \u201ccomposed of local Algerian skills\u201d and \u201cis open, for the future, to national skills established abroad\u201d.<\/p>\n \u201cTwo million doses of CoronaVac produced\u201d<\/strong><\/p>\n While the production of Chinese vaccine in Algeria was launched on September 29, the CEO of the Saidal group said that 2 million doses of vaccines have been produced so far. The Ministry of Pharmaceutical Industry recently announced the start of the marketing of the said vaccine.<\/p>\n \u201cWe can produce, according to our contract with the Chinese partner, up to 96 million doses per year,\u201d she said.<\/p>\n A quantity \u201cwhich will satisfy and the national market is international\u201d, estimates Fatoum Akacem.<\/p>\n On the export side, continues the manager, the targeted markets are the countries of West Africa and Central Africa in negotiation with the Chinese partner, as stipulated by the contract binding the two parties.<\/p>\n \u201cWe can already export, but some countries require accreditation from the WHO (World Health Organization, editor\u2019s note), explains the CEO of Saidal, specifying that the exchanges have progressed well and a WHO expert is expected shortly. in Algeria.<\/p>\n pipanews.com and APS\u00a0 January 16, 2022<\/p>\n","protected":false},"excerpt":{"rendered":" The pharmaceutical group Saidal has set up its first bioequivalence center which will start operating \u201cin less than two weeks\u201d, declared Fatoum…<\/p>\n","protected":false},"author":70,"featured_media":43818,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[15,12,4,8,6,9],"tags":[],"class_list":["post-43817","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-algeria","category-economy","category-featured-articles","category-health","category-latest-articles","category-science"],"yoast_head":"\n